Delayed fertilization during in vitro fertilization and embryo transfer cycles: analysis of causes and impact on overall results

Size: px
Start display at page:

Download "Delayed fertilization during in vitro fertilization and embryo transfer cycles: analysis of causes and impact on overall results"

Transcription

1 FERTILITY AND STERILITY Copyright" 1989 The American Fertility Society Printed on ocid free paper in U.S.A. Delayed fertilization during in vitro fertilization and embryo transfer cycles: analysis of causes and impact on overall results Sergio Oehninger, M.D. Anibal A. Acosta, M.D. Lucinda L. Veeck, M.L.T. (A.S.C.P.) Simonetta Simonetti, M.S. Suheil J. Muasher, M.D. The Howard and Georgeanna Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Medical College of Hampton Roads, Norfolk, Virginia This study evaluated possible causes of delayed fertilization during in vitro fertilization (IVF) cycles, its repetitiveness, and its influence on IVF results in 23 patients (27 cycles) with delayed fertilization of ~1 preovulatory oocyte(s). In 15 cycles, reinsemination with husband's semen was performed at 18 hours. Possible causes of delayed fertilization were oocyte defects (10 cycles, 37.0%), sperm defects (4 cycles, 14.8%), oocyte and sperm defects (4 cycles, 14.8%), and no detectable gamete defects (9 cycles, 33.3%). Overall fertilization rate was 47.9%. No pregnancies were observed in 10 patients with one embryo transferred. Recurrence rate of delayed fertilization per patient was 17.3%; overall ongoing pregnancy rate/cycle was 10.3%. Although repetitiveness of delayed fertilization is low, it seems to impact negatively on IVF results. Fertil Steril52:991, 1989 The success of fertilization in in vitro fertilization (IVF) relies upon several factors, including gamete(s) adequate in quality and quantity, strict laboratory control, and timed oocyte insemination. In the Norfolk IVF program the overall fertilization rate for preovulatory oocytes, including male factor patients, has been maintained at approximately 85%.1 We have reported that the incidence of failed fertilization represents approximately 5% of attempts and that sperm abnormalities can be identified as causal factors in a high percentage of cases. 1 Absence of distinct pronuclear formation by 18 to 20 hours after oocyte insemination, followed by the late appearance of pronuclei and extrusion of the second polar body, has been referred to as delayed fertilization. 2,3 Delayed fertilization can occur spontaneously or after oocyte reinsemination, Received May 18, 1989; revised and accepted July 26, Reprint requests: Sergio Oehninger, M.D., Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, 825 Fairfax Avenue, Norfolk, Virginia usually with a new, fresh semen sample. Trounson and Webb 2 reported that reinsemination did not enhance fertilization rates compared with controls, in whom spontaneous, delayed fertilization had occurred without reinsemination. On the other hand, Ben-Rafael et a1. 3 observed a fertilization rate of approximately 27% after reinsemination, associated with a high polyspermic rate (29%). They achieved pregnancy in 7/66 patients when embryos derived from reinseminated oocytes were transferred along with those fertilized on initial insemination. These authors therefore recommended reinsemination to increase the overall fertilization rate. Boldt et a1. 4 also reported that reinsemination was associated with substantially higher fertilization rates (40% to 70%), thereby increasing the number of embryos available for transfer. The potential value of oocyte reinsemination was reflected in the birth of one infant subsequent to the transfer of embryos derived solely from successful reinsemination. The objectives of this study were (1) to investigate the possible gamete (oocyte and/or spermato- Oehninger et ai. Delayed fertilization during IVF 991

2 zoa) defect(s) associated with delayed fertilization to try to establish a causative role; (2) to evaluate the results in cases where reinsemination was performed versus cycles in which "spontaneous" delayed fertilization occurred, and (3) to determine the repetitiveness of this phenomenon and its overall influence on IVF results. MATERIALS AND METHODS During Norfolk series 25 to 33 (October 1986 to December 1988) 867 patients underwent 1462 IVF cycles (1,321 transfers). Twenty-three patients (2.6% of patients) were identified as having had one or more cycles with delayed fertilization for a total of 27 cycles (1.8% of cycles) and an overall total of 58 cycles (including all other cycles without delayed fertilization). Delayed fertilization was defined as the absence of distinct pronuclei 18 to 20 hours after oocyte insemination, with delayed appearance of male and female pronuclei spontaneously or after oocyte reinsemination, as discussed below. Only preovulatory oocytes (metaphase I and II at aspiration) were considered. Patients in the study group were treated by IVF for primary infertility (n = 15) or secondary infertility (n = 8). Their mean age was 35.6 ± 0.8 (x ± standard error [SE]) years, with a range of 30 to 40. The primary indications for IVF were tubal factor (8 patients), tubal and male factor (6 patients), endometriosis and male factor (2 patients), dysovulatory and male factor (2 patients), male factor (3 patients), and endometriosis (2 patients). In 13 patients a male factor was involved, alone or in combination with female factors, as the cause of infertility. All semen parameters except sperm morphology were evaluated according to the established World Health Organization (WHO) criteria.5 Morphology was evaluated by the strict criteria of the Norfolk andrology laboratory.6 Immunologic investigations (of semen and serum antisperm antibodies) and the hamster ova/human sperm penetration assay (SPA) were performed according to published protocols. 7,8 Diagnosis of a male factor was established when sperm concentration was <20 X 106/mL, progressive motility < 50% (WHO criteria),5 normal morphology < 14%,6 and/or penetration rate in the SPA < 10%,8 The specific semen and systemic abnormalities found in these men were severe teratozoospermia and abnormal SPA (five patients), severe teratozoospermia with asthenozoospermia and abnormal SPA (one patient), oligoasthenozoospermia with severe teratozoospermia and abnormal SPA (two patients), mild teratozoospermia (four patients), and systemic (serum only) antisperm antibodies (one patient). Severe teratozoospermia was defined as <4 % normal forms ("poor" prognosis pattern), whereas mild teratozoospermia was defined as 4 % to 14% normal forms ("good" prognosis pattern),6 The female partners (normally menstruating women) were assessed by the basic infertility workup required in the Norfolk program1 and also by determinations of serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) on cycle day 3, We have reported that these values are helpful in predicting stimulation response and IVF outcome (normal laboratory range for FSH and LH: 5 to 20 miu/ml).9,1o Seven patients had abnormal endocrine profiles in addition to other primary causes of infertility. These abnormalities were elevated FSH levels (>20 miu/ml) in four patients and LH/FSH > 2/1 in three other patients. The IVF procedures used for ovarian stimulation (a combination of 2 FSH/2 human menopausal gonadotropin [hmg]/human chorionic gonadotropin [hcg] or "pure" FSH/hCG), sperm preparation, oocyte classification, insemination and culture, and embryo transfer in the Norfolk program have been described. ll,12 In our experience all of these stimulation protocols have demonstrated provision of preovulatory oocytes with identical fertilization rates.13 Each patient was further categorized according to her plasma estradiol (E2) response pattern. ll Oocyte retrieval was performed by laparoscopy or by the transvaginal ultrasonically guided approach, as reported. 14 In an effort to improve stimulation response and/or IVF results, we switched patients who returned to the program to different stimulation protocols (modification of the basic combination gonadotropin protocol, pure FSH in low or high doses, 2 to 6 ampules/d15,16) or to concomitant use of a gonadotropin-releasing hormone agonisty Other corrective measures implemented in subsequent attempts included modification in the sperm insemination concentrations, where indicated,13 and the use of a cryopreserved donor semen sample (one patient). For patients with normal sperm parameters, timed oocyte insemination was performed with the standard concentration of 50,000 motile sperm/ 992 Oehninger et al. Delayed fertilization during IVF Fertility and Sterility

3 Table 1. Stimulation Protocols and Serum E2 Response Patterns ill 27 Cycles with Delayed Fertilization Stimulation protocol 2 FSH/2hMG 6FSH 4FSH 2FSH GnRHa/2 FSH/2 hmg Serum E2 response pattern High Intermediate Low No. of cycles ml/oocytep After April 1987 the insemination concentration of male factor patients, especially those with teratozoospermia, was increased to 5~0,000 to 1,000,000 motile sperm/ml/oocyte, with a remarkable improvement in the fertilization rate.13 The oocytes were evaluated for signs offertilization at 12 to 20 hours after insemination (15 to 26 hours after retrieval). If they were judged to be unfertilized by 20 hours, (a) either they were transferred to a new culture dish containing fresh medium and were reinseminated, usually with a freshly obtained semen sample; ifthis was not feasible, the initially washed motile sperm fraction was used if it still displayed good motility. (These reinseminated oocytes were reexamined 12 to 18 hours later for evidence of fertilization.) Reinsemination was performed in 9 ofthe 13 male factor patients and in 4 patients without semen abnormalities. Or (b) if other mature oocytes from the cohort had fertilized, or if the quality and quantity of the sperm population attached to the zona pellucida or in close contact with the oocyte investments was judged to be adequate, they were observed for 10 to 12 more hours to assess whether spontaneous delayed fertilization could occur. Results of the study group were compared with those of the overall population attempting IVF during the same time frame. Statistical analyses were performed by x2 and the student's t-test where appropriate. P levels < 0.05 were considered significant. Results are expressed as the mean ±SE. RESULTS The stimulation protocols used and the serum E2 response patterns for the 27 cycles with delayed fertilization are shown in Table 1. In 19 cycles the E2 response was intermediate, in 2 cycles it was high (associated with a multi-follicular ovarian response and a high basal serum LH/FSH ratio) 15,18 and in 6 cycles it was low (in 4 cases with a ~erimenopausal pattern of high basal serum FSH levels).19 In the 27 cycles, a total of 123 preovulatory 00- cytes (61 metaphase I, 62 metaphase II) were recovered. Thirty-nine of the 123 oocytes (31.7%) showed delayed fertilization. In 15 of these cycles reinsemination with husband's semen had bee~ performed, whereas in 12 cycles spontaneous-delayed fertilization was observed. Ofthe oocytes displaying delayed fertilization, 61.5% were metaphase I and 38.4 % were metaphase II at aspiration. The overall fertilization rate per oocyte for the 27 cycles was 47.9% (59/123 oocytes), significantly lower than that of controls (5027/5818, 86.4%; P < ). The polyspermia rate was 7.3% (9/123) versus 9.5% (477/5027) in controls, not significantly different. Gamete abnormalities found in these cycles were as follows. (Table 2): oocyte defects (10 cycles, 37.0%), either purely morphological (refractile bodies,20 vacuolar ooplasm) or associated with an abnormal endocrine profile (perimenopausal pattern,19 multi-follicular ovarian response associated with high serum E2 levels in the periovulatory period);15,18 sperm defects (4 cycles, 14.8%), severe impairment of sperm motility and/or morphology6 «4% normal sperm forms), combined with poor penetration rates in the SPA; a combination of oocyte and sperm abnormalities (4 cycles, 14.8%), and no gamete defects (unexplained; 9 cycles, 33.3%). The fertilization rates for each subgroup were significantly different (2 X 4 contingency table, P < 0.005), being lowest for the group with sperm defects (14.2%) and highest in the group with no ga- T~ble 2 Gamete Abnormalities Found in 27 Cycles with Delayed Fertilization No. of cycles Fertilization rate a % % Sperm abnormalities 4 (14.8) 4/28 (14.2) Oocyte defects 10 (37.0) 15/28 (53.5) Oocyte + sperm defects 4 (14.8) 13/32 (40.6) No abnormalities (unexplained) 9 (33.3) 27/35 (77.1)." The fertilization rate was significantly lower in the group with sperm abnormalities than in the other three groups. Oehninger et al. Delayed fertilization during IVF 993

4 Table 3 Analysis of Etiologic Factors in the Seven Patients Who Achieved a Pregnancy in the 58 Attempted IVF Cycles Patient Gamete abnormalities Sporadic/recurrent Female diagnosis Male diagnosis 1 None (unexplained) Recurrent (2/2 cycles) Tubal Normal Normal 2 None (unexplained) Sporadic (1/2 cycles) Tubal Sporadic (1/3 cycles) Endometriosis Normal 3 None (unexplained) 4 None (unexplained) Recurrent (2/5 cycles) LH/FSH> 2 Normal FSH> 20 mid /ml Normal 5 Oocyte Sporadic (1/4 cycles) 6 Oocyte 1 cycle LH/FSH> 2 Systemic immunologic 7" Sperm 1 cycle Normal Severe oligospermia " Pregnant in second cycle using donor semen. mete or endocrine abnormalities (unexplained, 77.1 %). Individual x 2 analyses showed that the fertilization rate from the group with sperm abnormalities was significantly lower than from the groups with oocyte defects (P < 0.005), oocyte and sperm defects (P < 0.03), and unexplained (P < ). The mean number of embryos transferred in the 27 cycles was 2.7 ± 0.1, and the mean number of blastomeres at transfer was 3.0 ± 0.4, values not significantly different from those of controls. Only three pregnancies were achieved, for an ongoing pregnancy rate per transfer of 11.1 %. No pregnancies were observed in 10 patients (13 cycles) in whom only one embryo was transferred (derived from a mature oocyte that displayed delayed fertilization). All three pregnancies were achieved after the transfer of embryos derived both from oocytes initially fertilized and those displaying delayed fertilization. The pregnancy rate with only one embryo transferred in the control group was 12%. Besides these 27 cycles, patients from the study group had 31 additional cycles without evidence of delayed fertilization, for an overall total of 58 cycles. The overall ongoing pregnancy rate/transfer was 10.3% (6 pregnancies in 58 cycles). (Another patient achieved a pregnancy using donor semen in a case of severe male factor infertility). This figure was lower than in the control group (17.6%; 233 ongoing pregnancies/1321 transfers), although not significantly different. Table 3 presents an analysis of the etiologic factors encountered in the seven patients who became pregnant in the 58 attempted IVFcycles. The recurrence rate of delayed fertilization was 17.3%/patient (4/23) in the 58 cycles (8 cycles with delayed fertilization in 11 attempted cycles). In three of these patients no gamete abnormalities were detected; in the remaining patient a repetitive oocyte problem was observed, associated with fer- tilization delay in combination with a 50% polyspermic rate. Reinsemination versus Spontaneous Delayed Fertilization Of the 15 cycles in which the oocytes (n = 23) were reinseminated, the overall fertilization rate was 42.3% (33/78). The success rate of reins emination was 33.8% (23/68 oocytes that had not fertilized initially). Gamete abnormalities were equally distributed among this group, although the absence of any detectable gamete defects was most common (33.3% of cycles) (Table 4). In the 12 cycles with spontaneous delayed fertilization (n = 26 oocytes), the overall fertilization rate was 57.7% (26/45). The success of observation or watchful expectancy3 was 45.7% (16/35 oocytes that had not fertilized initially). Oocyte defects were found in 58.3% of these cycles. DISCUSSION A few studies have investigated the value of reinseminating oocytes that failed to fertilize within 15 to 20 hours after initial insemination or the option of adopting a watchful expectancy that delayed spontaneous fertilization would occur. 2-4 This is the first investigation of the possible causes of this phenomenon, its prognostic significance, and its repetitiveness. Oocyte defects were observed in 37.0% of the cycles with delayed fertilization; this could be the postulated cause for its occurrence. Veeck 20,21 established that oocytes with atypical morphology fail to fertilize in a high percentage of cases. She reported that oocytes with refractile bodies (multivesicular structures with lipid droplets, associated with dense granules, small vesicles, and fibrillar material) fertilized in only 2% of the cases, com- 994 Oehninger et al. Delayed fertilization during IVF Fertility and Sterility

5 Table 4 Comparison of Oocyte Reinsemination versus "Spontaneous" Delayed Fertilization Oocytes Oocytes fertilized/ Overall fertilized/ reinseminated or No. of No. of fertilization "initially" "observed" Major gamete ongoing cycles rate inseminated oocytes abnormalities pregnancies % % % % Oocyte reinsemination Unexplained 1 (33/78) (10/78) (23/68) (33.3) "Spontaneous" Oocyte defects 2 delayed fertilization (26/45) (10/45) (16/35) (58.3) All 3 pregnancies were achieved after transfer of embryos derived both from "initially" and "delayed" fertilized oocytes. pared with an 86% fertilization rate in controls (metaphase II oocytes with normal morphology). In addition, preovulatory oocytes with atypical characteristics of the first polar body at collection demonstrated lower fertilization rates (50% to 75%) together with an increase in abnormal fertilization (13% to 19%) compared with controls.21 It is tempting to speculate that there is a wide spectrum of oocyte atypias or dysfunctions that result in delayed fertilization, polyspermic fertilization, or complete failure of fertilization. The oocyte itself appears to control, at least partially, crucial stages of the fertilization process such as establishing the block to polyspermia, promoting sperm nuclear head decondensation, and resuming an active metabolic state during activation.22 Oocytes of poor morphological or functional quality may fail totally or partially during this process, leading to fertilization abnormalities. Whether these oocytes of poor quality are intrinsically abnormal or are the result of exogenous ovarian stimulation and an unfavorable endocrine milieu remains to be determined.15,18,19 Plachot et al. 23 reported that the rates of chromosomal anomalies and mosaicism are drastically increased in delayed fertilization; maternal age but not the type of infertility or the type of stimulation was associated with the chromosome anomalies that they found. Spontaneous fertilization or fertilization after reinsemination always raises the possibility of oocyte immaturity3 and inadequate maturation diagnosis at retrieval, leading to improperly timed oocyte insemination. In our embryology laboratory we routinely use Veeck's cumulus spreading technique for correct identification of the oocyte nuclear state.21 Knowledge of maturational status (prophase I, metaphase I and II) allows for a more accurate timing of insemination, and Veeck has reported a slight increase in normal fertilization rates along with a slight decrease in triploidy with this technique.21 Because the block to polyspermia is a reversible phenomenon,24 it could also be postulated that some oocytes could undergo premature release of cortical granules content with an initial block to polyspermia, followed by a reversal of this phenomenon, thus allowing for delayed fertilization to occur. This hypothetical mechanism might occur in aging oocytes and/or oocytes with other dysfunctions. Severe sperm abnormalities, alone or in combination with oocyte defects, were associated with delayed fertilization in 29.6% of the cycles. This may suggest an involvement of the male gamete in some cases of delayed fertilization. This is not surprising, because we have diagnosed sperm defects in 70% of patients with failed fertilization in IVF.l A low-motility and a high percentage of abnormal sperm forms have been associated with poor fertilization rates in IVF.13,25 Also poor and failed penetration in the SPA have been observed in patients with failed IVF. 8 On the other hand, the presence of serum or semen antisperm antibodies has not been shown to affect IVF results negatively in our program.25 The involvement ofthe male gamete in the fertilization process is apparently very complex and other subtle sperm dysfunctions could lead to abnormal or delayed fertilization. Sperm binding to the zona pellucida is a critical initial step of fertilization, and we have reported that patients with failed fertilization show significantly decreased tight binding to the zona than patients with successful fertilization in IVF, as evaluated by the hemi-zona assay.25 Whether dysfunctional sperm/ zona pellucida interactions, failure, or retardation of the sperm triggering of oocyte activation,22 or abnormal interactions between oocyte cytosolic factors and a spermatozoon could be one of the under- Oehninger et ai. Delayed fertilization during IVF 995

6 lying causes of delayed fertilization remains to be established. In 33.3% of the cycles with delayed fertilization, no gamete defects were observed and no major endocrine abnormalities could be diagnosed (unexplained). It is hypothesized that subtle gamete dysfunction(s) at an unknown stage of the fertilization process may have contributed to the delay in these patients. In 17.3% of the patients (72.8% of their cycles) delayed fertilization occurred as a repetitive phenomenon. This finding suggests that in some patients intrinsic and permanent gamete defects are the subjacent cause. In the remaining cases, delayed fertilization was sporadic, raising the possibility that intercurrent factors played a predominant role (changes in gamete microenvironment? endocrine milieu? in vitro culture conditions?). The latter possibility appears to be extremely unlikely because of the strict quality control and rigorous culture conditions that rule our IVF laboratory. Similar success rates were observed in reinsemination and spontaneous delayed fertilization (33.8% and 45.7%, respectively). However, one should not be misled by this high -efficiency of reinsemination since, by study design, all these patients achieved fertilization. On the contrary, the real success rate of reinsemination for the control group was only 2.8% (23 oocytes with second insemination success per 814 total oocytes with initial failure of fertilization). This figure is more in agreement with that reported by Trounson and Webb,2 who found a 13% fertilization rate following reinsemination using a freshly collected semen sample. That the overall fertilization rates were low in the groups with reinsemination and delayed fertilization (42.3% and 57.7%, respectively) points to the fact that delayed fertilization may be an epiphenomenon of a more profound fertilization defect. Even though three pregnancies were achieved in the 27 cycles with delayed fertilization, in all cases there was a mixture of transferred embryos derived both from oocytes initially fertilized and from 00- cytes with delayed fertilization. That no pregnancies were observed when only one embryo, derived from an oocyte with delayed fertilization, was transferred, plus the low-ongoing pregnancy rate/ transfer of all IVF cycles in this population, suggests that the reproductive performance of these patients is impaired. In conclusion: cycles with delayed fertilization are associated with demonstrable gamete defects in 66% of the cases. Although the repetitiveness of the phenomenon is low, it seems to have a negative impact on IVF results. Acknowledgments. The authors thank Richard Scott, M.D., for helpful discussions during the preparation of the manuscript, Charlotte Schrader, Ph.D., for editorial assistance, and Ms. Debbie Jones for computer assistance. REFERENCES 1. Oehninger S, Acosta AA, Kruger T, Veeck LL, Flood J, Jones HW, Jr: Failure of fertilization in in vitro fertilization: the "occult" male factor. J In Vitro Fert Embryo Trans 5:181, Trounson A, Webb J: Fertilization of human oocytes following reinsemination in vitro. Fertil Steril41:816, Ben-Rafael Z, Kopf GS, Blasco L, Tureck RW, Mastroianni L, Jr: Fertilization and cleavage after reinsemination of human oocytes in vitro. Fertil Steril45:58, Boldt J, Howe A, Butler WJ, McDonough P, Padilla SL: The value of oocyte reinsemination in human in vitro fertilization. Fertil SteriI48:617, W orid Health Organization: Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. Cambridge, University Press, Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S: Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril49:112, Acosta AA, Chillik CF, Brugo S, Ackerman S, Swanson RJ, Pleban P, Yuan J, Haque D: In vitro fertilization and the male factor. Urology 28:1, Kruger TF, Hamilton M, Simmons KF, Swanson RJ, Acosta AA, Matta JF, Oehninger S, Morshedi M: The significance of abnormal sperm morphology and other sperm parameters in the outcome of the hamster ova/human sperm penetration assay. Int J Androl11:107, Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu H-C, Jones GS, Rosenwaks Z: The value of basal and/ or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril50:298, Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril51:651, Acosta AA, Bernardus R, Jones GS, Garcia J, Rosenwaks Z, Simonetti S, Veeck LL, Jones D: The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization. Acta Eur FertiI16:81, Veeck LL: Extracorporeal maturation: Norfolk Ann NY Acad Sci 442:357, Oehninger S, Acosta AA, Morshedi M, Veeck L, Swanson RJ, Simmons K, Rosenwaks Z: Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities. Fertil Steril 50: 283, Oehninger et al. Delayed fertilization during IVF Fertility and Sterility

7 Oehninger S, Scott R, Muasher SJ, Acosta AA, Jones HW, Jr, Rosenwaks Z: Effects ofthe severity oftubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embryo transfer. Fertil Steril51:126, 1989 Muasher SJ: Stimulation protocols for patients with "atypical response." Ann NY Acad Sci 541:82,1988 Hofmann GE, Toner JP, Muasher SJ, Jones D, Liu H-C, Jones GS: High-dosage follicle stimulating hormone (FSH) ovarian stimulation in low responder patients with high basal serum FSH for in vitro fertilization. (Abstr. 052) Presented at the 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 10 to 13, Published by the American Fertility Society, Birmingham, Alabama, 1989, p S18 Droesch K, Muasher SJ, Brzyski RG, Jones GS, Simonetti S, Liu H-C, Rosenwaks Z: Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril51:292, 1989 Romeu A, Muasher S, Acosta AA, Liu H-C, Rosenwaks Z: Hormonal and follicular behavior of patients displaying multifollicular ovarian response (MOR) when undergoing IVF with different stimulation protocols. (Abstr. PP-5) Presented at the 5th World Congress on In Vitro Fertiliza- tion and Embryo Transfer, Norfolk, Virginia, April 5 to 10, Published by the American Fertility Society in the Program Supplement, 1987, p Jones GS, Muasher SJ, Rosenwaks Z, Acosta AA, Liu H-C: The premenopausal patient in in vitro fertilization: the use of gonadotropin-releasing hormone. Fertil Steril 46:885, Veeck LL: Atlas of the Human Oocyte and Early Conceptus. Baltimore: Williams Wilkins, 1986, p Veeck LL: Oocyte assessment and biological performance. Ann NY Acad Sci 541:259, Yanagimachi R: Mammalian fertilization. In The Physiology of Reproduction, Edited by E Knobil, JD Neill. Raven Press, 1988, p Plachot M, de Grouchy J, Junca AM, Mandelbaum J, Salat-Baroux J, Cohen J: Chromosome analysis of human 00- cytes and embryos: does delayed fertilization increase chromosome inbalance? Hum Reprod 3:125, Gulyas BJ: Electron microscopic observation on advanced stages of spontaneous polyspermy in rabbit zygotes. Anat Rec 179:285, Acosta AA, Oehninger S, Morshedi M, Swanson RJ, Scott R, Irianni F: Assisted reproduction in the diagnosis and treatment of the male factor. Obstet Gynecol Surv 44:1, 1989 Oehninger et al. Delayed fertilization during IVF 997

Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities

Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities FERTILITY AND STERILITY Copyright e 1988 The American Fertility Society Printed in U.S.A. Corrective measures and pregnancy outcome in in vitro fertilization in patients with severe sperm morphology abnormalities

More information

Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization*

Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization* FERTILITY AND STERILITY Copyright C> 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Inter variability of day 3 follicle-stimulating hormone levels and its effect on stimulation

More information

In Vitro Fertilization and Embryo Transfer

In Vitro Fertilization and Embryo Transfer Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,

More information

Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer~*

Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer~* FERTILITY AND STERILITY Copyright 0 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in

More information

The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt*

The predictive value of idiopathic failure to fertilize on the first in vitro fertilization attempt* FERTILITY AND STERILITY Copyright 1991 The American Fertility Society Printed on acid-free paper in U.S.A. The predictive value of idiopathic failure to fertilize on the first in vitro fertilization

More information

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles

Complete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles r FERTILITY AND STERILITY Copyright ~ 1993 The American Fertility Society Printed on acid-free paper in U.S.A. Complete failure of fertilization in couples with unexplained infertility: implications for

More information

Use of a specific zona pellucida (ZP) protein 3 antiserum as a clinical marker for human ZP integrity and function*

Use of a specific zona pellucida (ZP) protein 3 antiserum as a clinical marker for human ZP integrity and function* FERTILITY AND STERILITY Copyright 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Use of a specific zona pellucida (ZP) protein 3 antiserum as a clinical marker for

More information

Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization*

Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization* FERTILITY AND STERILITY Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program

More information

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.

Timur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D. FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating

More information

Induction of the human sperm acrosome reaction by human oocytes*

Induction of the human sperm acrosome reaction by human oocytes* FERTILITY AND STERILITY Copyright C> 1988 The American Fertility Society Vol. 50, No.6, December 1988 Printed in U.S.A. Induction of the human sperm acrosome reaction by human oocytes* Christopher J. De

More information

Fertilization, cleavage, and cytogenetics of 48-hour zona-intact and zona-free human unfertilized oocytes reinseminated with donor sperm

Fertilization, cleavage, and cytogenetics of 48-hour zona-intact and zona-free human unfertilized oocytes reinseminated with donor sperm FERTLTY AND STERLTY Copyright 1992 The American Fertility Society Vol. 57, No. 1, January 1992 Printed on acid free paper in U.S.A. Fertilization, cleavage, and cytogenetics of 48-hour zona-intact and

More information

Infertility treatment

Infertility treatment In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation

More information

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: PA.018.MH Last Review Date: 08/04/2016 Effective Date: 01/01/2017 MedStar Health, Inc. POLICY AND PROCEDURE MANUAL PA.018.MH Infertility- Treatment This policy applies to the following lines of business: MedStar Employee (Select) MedStar MA DSNP CSNP (Not Covered) MedStar

More information

Copyright 1995 American Society for Reproductive Medicine

Copyright 1995 American Society for Reproductive Medicine FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid free paper in U. S. A. Prospective, auto-controlled study on reinsemination

More information

Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*

Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age* FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance

More information

The importance of the follicular phase to success and failure in in vitro fertilization

The importance of the follicular phase to success and failure in in vitro fertilization ,e ~t FERTILITY AND STERILITY Copyriht 0 1983 The American Fertility Society Printed in U.SA. The importance of the follicular phase to success and failure in in vitro fertilization Howard W. Jones, Jr.,

More information

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde

P.M.M.Kastrop 1, S.M.Weima, R.J.Van Kooij and E.R.Te Velde Human Reproduction vol.14 no.1 pp.65 69, 1999 Comparison between intracytoplasmic sperm injection and in-vitro fertilization (IVF) with high insemination concentration after total fertilization failure

More information

Rafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D.

Rafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant

More information

Defective sperm zona pellucida interaction: a major cause of failure of fertilization in clinical in-vitro fertilization

Defective sperm zona pellucida interaction: a major cause of failure of fertilization in clinical in-vitro fertilization Human Reproduction vol.15 no.3 pp.702 708, 2000 Defective sperm zona pellucida interaction: a major cause of failure of fertilization in clinical in-vitro fertilization D.Y.Liu 1 and H.W.G.Baker However,

More information

in vitro fertilization

in vitro fertilization FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal

More information

Vital initiation of pregnancy (VIP) using human menopausal gonadotropin and human chorionic gonadotropin ovulation induction: Phase

Vital initiation of pregnancy (VIP) using human menopausal gonadotropin and human chorionic gonadotropin ovulation induction: Phase FERTILITY AND STERILITY Copyright 1983 The American Fertility Society Printed in U.SA. i i Vital initiation of pregnancy (VIP) using human menopausal gonadotropin and human chorionic gonadotropin ovulation

More information

FERTILITY AND STERILITY Vol. 55, No.6, June 1991

FERTILITY AND STERILITY Vol. 55, No.6, June 1991 Assisted technology roductive FERTILITY AND STERILITY Vol. 55, No.6, June 1991 Copyright ~ 1991 The American Fertility Society Printed on acid-free paper in U.S.A. Possible role of pure human follicle-stimulating

More information

The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer*

The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer* FERTILITY AND STERILITY Copyright 0 1989 The American Fertility Society Printed on acid-free paper in U.S.A. The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro

More information

Utility of in vitro fertilization at diagnostic laparoscopy*

Utility of in vitro fertilization at diagnostic laparoscopy* FERTILITY AND STERILITY Copyright" 1994 The American Fertility Society Printed on acid-free paper in U. S. A. Utility of in vitro fertilization at diagnostic laparoscopy* Paul R. Gindoff, M.D.t Jerry L.

More information

Kersti Lundin 1, Brita Söderlund and Lars Hamberger

Kersti Lundin 1, Brita Söderlund and Lars Hamberger Human Reproduction vol.12 no.12, pp.2676 2681, 1997 The relationship between sperm morphology and rates of fertilization, pregnancy and spontaneous abortion in an in-vitro fertilization/intracytoplasmic

More information

Unexplained infertility Evidence based management

Unexplained infertility Evidence based management Unexplained infertility Evidence based management Dr Mark Hamilton Consultant Gynaecologist NHS Grampian/University of Aberdeen m.hamilton@abdn.ac.uk www.iffs-reproduction.org @IntFertilitySoc Int@FedFertilitySoc

More information

Results and Discussion

Results and Discussion The AMH and Inhibin B in serum and follicular fluid was a very good predictive marker for assessment of oocyte quantity but did not correlate with the maturity of the oocyte or fertilization or reproductive

More information

A preclinical evaluation of pronuclear formation by microinjection of human spermatozoa into human oocytes

A preclinical evaluation of pronuclear formation by microinjection of human spermatozoa into human oocytes FERTILITY AND STERILITY Copyright c 1988 The American Fertility Society Vol. 49, No.5, May 1988 Printed in U.S.A. A preclinical evaluation of pronuclear formation by microinjection of human spermatozoa

More information

Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles

Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Human Reproduction Vol.17, No.1 pp. 83 87, 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles Joseph E.Peña, Peter L.Chang 1, Lai-King Chan, Khaled

More information

Prediction of the rates of fertilization, cleavage, and pregnancy success by cumulus-coronal morphology in an in vitro fertilization program

Prediction of the rates of fertilization, cleavage, and pregnancy success by cumulus-coronal morphology in an in vitro fertilization program FERTILITY AND STERILITY VOL. 72, NO. 3, SEPTEMBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Prediction of the

More information

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony*

Superovulation with human menopausal gonadotropins is associated with endometrial gland-stroma dyssynchrony* aes FERTILITY AND STERILITY Vol. 61, No.4, April 1994 Copyright ee) 1994 The American Fertility Society Printed on acid-free paper in U. S. A. r I Superovulation with human menopausal gonadotropins is

More information

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations

Infertility. Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Infertility Review and Update Clifford C. Hayslip MD Intrauterine Inseminations Beneficial effects of IUI not consistently documented in studies No deleterious effects on fertility 3-4 cycles of IUI should

More information

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various

More information

Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization

Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization FERTILITY AND STERILITY Copyright ~ 1983 The American Fertility Society Vol. 39, No.5, May 1983 Printed in U.SA. Maturation and fertilization of morphologically immature human oocytes in a program of in

More information

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation

More information

Bleeding and spontaneous abortion after therapy for infertility

Bleeding and spontaneous abortion after therapy for infertility FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Bleeding and spontaneous

More information

LOW RESPONDERS. Poor Ovarian Response, Por

LOW RESPONDERS. Poor Ovarian Response, Por LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients

More information

Elena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a

Elena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle

More information

2017 United HealthCare Services, Inc.

2017 United HealthCare Services, Inc. UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1143-4 Program Prior Authorization/Notification Medication Menopur (menotropins) * P&T Approval Date 8/2014, 5/2015, 5/2016, 5/2017

More information

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve

More information

IN VITRO FERTILIZATION OF RABBIT EGGS IN OVIDUCT SECRETIONS FROM DIFFERENT DAYS BEFORE AND AFTER OVULATION*

IN VITRO FERTILIZATION OF RABBIT EGGS IN OVIDUCT SECRETIONS FROM DIFFERENT DAYS BEFORE AND AFTER OVULATION* FERTILITY AND STERILITY Copyright~ 1975 The American Fertility Society Vol. 26, No.7, July 1975 Printed in U.SA. IN VITRO FERTILIZATION OF RABBIT EGGS IN OVIDUCT SECRETIONS FROM DIFFERENT DAYS BEFORE AND

More information

Sperm nuclear chromatin normality: relationship with sperm morphology, sperm-zona pellucida binding, and fertilization rates in vitro*

Sperm nuclear chromatin normality: relationship with sperm morphology, sperm-zona pellucida binding, and fertilization rates in vitro* FERTILITY AND STERILITY Copyright Q 1992 The American Fertility Society Vol. 58, No.6, December 1992 Printed on acid-free paper in U.S.A. Sperm nuclear chromatin normality: relationship with sperm morphology,

More information

IVF treatment should not be postponed for patients with high basal FSH concentrations

IVF treatment should not be postponed for patients with high basal FSH concentrations Reproductive BioMedicine Online (2010) 21, 631 635 www.sciencedirect.com www.rbmonline.com SHORT COMMUNICATION IVF treatment should not be postponed for patients with high basal FSH concentrations Ettie

More information

Evaluation of basal estradiol levels in assisted reproductive technology cycles

Evaluation of basal estradiol levels in assisted reproductive technology cycles FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Evaluation of basal

More information

Endometriosis impairs the efficacy of gamete intrafallopian transfer: results of a case-control study*

Endometriosis impairs the efficacy of gamete intrafallopian transfer: results of a case-control study* FERTILITY AND STERILITY Vol. 62, No. 6, December 1994 Copyright 1994 The American Fertility Society Printed on acid-free paprr in U. 8. A. Endometriosis impairs the efficacy of gamete intrafallopian transfer:

More information

Study on Several Factors Involved in IVF-ET of Human Beings

Study on Several Factors Involved in IVF-ET of Human Beings Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,

More information

Human sperm penetration assay as an indicator of sperm function in human in vitro fertilization

Human sperm penetration assay as an indicator of sperm function in human in vitro fertilization FERTILITY AND STERILITY Copyright., 1987 The American Fertility Society Vol. 48, No. 2, August 1987 Printed in U.S.A. Human sperm penetration assay as an indicator of sperm function in human in vitro fertilization

More information

A Tale of Three Hormones: hcg, Progesterone and AMH

A Tale of Three Hormones: hcg, Progesterone and AMH A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,

More information

Utility of color Doppler indices of dominant follicular

Utility of color Doppler indices of dominant follicular Ultrasound Obstet Gynecol 2002; 20: 592 596 Utility of color Doppler indices of dominant follicular Blackwell Science, Ltd blood flow for prediction of clinical factors in in vitro fertilization-embryo

More information

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman IVM in PCOS patients Michael Grynberg René Frydman Department of Obstetrics and Gynecology A. Beclere Hospital, Clamart, France Maribor, Slovenia, 27-28 February 2009 Introduction (1) IVM could be a major

More information

Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome

Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome British Journal of Obstetrics and Gynaecology January 1998, Vol. 105, pp. 107-1 12 Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome Khaldoun Sharif Lecturer, Manal

More information

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Geneva Foundation for Medical Education and research Definitions

More information

Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine. Volume 72(4) October 1999 pp

Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine. Volume 72(4) October 1999 pp Fertility & Sterility Copyright 1999 American Society for Reproductive Medicine Volume 72(4) October 1999 pp 679-685 Embryo implantation in in vitro fertilization and intracytoplasmic sperm injection:

More information

Fred K. Kirchner, M.D.t B. Jane Rogers, Ph.D.*:j:

Fred K. Kirchner, M.D.t B. Jane Rogers, Ph.D.*:j: FERTILITY AND STERILITY Copyright c 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Establishment of TEST -yolk buffer enhanced sperm penetration assay limits for fertile males

More information

In vitro fertilization outcome in the presence of severe male factor infertility*

In vitro fertilization outcome in the presence of severe male factor infertility* FERTILITY AND STERILITY Vol. 63, No.5, May 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. In vitro fertilization outcome in the presence of severe

More information

Outcome of IVF in DES-Exposed Daughters: Experience in the 90s

Outcome of IVF in DES-Exposed Daughters: Experience in the 90s CLINICAL ASSISTED REPRODUCTION Outcome of IVF in DES-Exposed Daughters: Experience in the 90s LUBNA PAL,1,4 JAN L. SHIFREN,1 KEITH B. ISAACSON,1 YUCHIAO CHANG,2 MARTHA MAREAN,3 LUCY LEYKIN,1 and THOMAS

More information

Assisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION

Assisted Reproduction. Rajeevi Madankumar, 1,2 James Tsang, 1 Martin L. Lesser, 1 Daniel Kenigsberg, 1 and Steven Brenner 1 INTRODUCTION ( C 2005) DOI: 10.1007/s10815-005-4912-8 Assisted Reproduction Clomiphene citrate induced ovulation and intrauterine insemination: effect of timing of human chorionic gonadotropin injection in relation

More information

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

I. ART PROCEDURES. A. In Vitro Fertilization (IVF) DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

Puerto Rico Fertility Center

Puerto Rico Fertility Center Puerto Rico Fertility Center General Information of the In-Vitro Fertilization Program Dr. Pedro J. Beauchamp First test-tube baby IN PUERTO RICO Dr. Pedro Beauchamp with Adlin Román in his arms. Paseo

More information

Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles

Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles Reproductive BioMedicine Online (2012) 24, 148 152 www.sciencedirect.com www.rbmonline.com ARTICLE Cryptic sperm defects may be the cause for total fertilization failure in oocyte donor cycles Maria Goudakou

More information

STUDIES OF THE HUMAN UNFERTILIZED TUBAL OVUM*t

STUDIES OF THE HUMAN UNFERTILIZED TUBAL OVUM*t FERTILITY AND STERILITY Copyright @ 1973 by The Williams & Wilkins Co. Vol. 24, No.8, August 1973 Printed in U.S.A. STUDIES OF THE HUMAN UNFERTILIZED TUBAL OVUM*t C. NORIEGA, M.D., AND C. OBERTI, M.D.

More information

The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia

The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia FERTILITY AND STERILITY VOL. 72, NO. 4, OCTOBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Embryo implantation

More information

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol

Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko

More information

Validation of the hemizona assay in a monkey model: influence of oocyte maturational stages*

Validation of the hemizona assay in a monkey model: influence of oocyte maturational stages* FERTILITY AND STERILITY Copyright e 1989 The American Fertility Society Printed in U.S.A. Validation of the hemizona assay in a monkey model: influence of oocyte maturational stages* Sergio Oehninger,

More information

Department of Obstetrics and Gynaecology, University of Melbourne, Reproductive Biology Unit, Royal Women's Hospital, Melbourne, Victoria, Australia

Department of Obstetrics and Gynaecology, University of Melbourne, Reproductive Biology Unit, Royal Women's Hospital, Melbourne, Victoria, Australia FERTILITY AND STERILITY Copyright c 1988 The American Fertility Society Vol. 50, No. 2, August 1988 Printed in U.S.A. The proportion of human sperm with poor morphology but normal intact acrosomes detected

More information

Sperm morphologic features as a prognostic factor in in vitro fertilization

Sperm morphologic features as a prognostic factor in in vitro fertilization FERTILITY AND STERILITY Copyright c 1986 The American Fertility Society Printed in U.SA. Sperm morphologic features as a prognostic factor in in vitro fertilization Thinus F. Kruger, M.D.*t Roelof Menkveld,

More information

Prognostic value of day 3 estradiol on in vitro fertilization outcome*

Prognostic value of day 3 estradiol on in vitro fertilization outcome* FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization

More information

FAILED OOCYTE MATURATION. A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas

FAILED OOCYTE MATURATION. A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas FAILED OOCYTE MATURATION A Fekih, N Farah, D Chardonnens, F Urner, D De Ziegler, PG Bianchi, P Mock, A Campana, H Lucas INTRODUCTION In our laboratory,we perform (X) IVF and (Y) ICSI per year with a success

More information

A comparison of the effects of estrus cow. nuclear maturation of bovine oocytes

A comparison of the effects of estrus cow. nuclear maturation of bovine oocytes A comparison of the effects of estrus cow serum and fetal calf serum on in vitro nuclear maturation of bovine oocytes J Spiropoulos, SE Long University of Bristol, School of Veterinary Science, Department

More information

Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments

Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments IN VITRO FERTILIZATION Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments Daniela Nogueira, Ph.D., a Shevach

More information

Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome

Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome Effects of triploidy after intracytoplasmic sperm injection on in vitro fertilization cycle outcome Molina B. Dayal, M.D., M.P.H., Paul R. Gindoff, M.D., Abbaa Sarhan, M.D., Anil Dubey, Ph.D., Douglas

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Applicable Medical Benefit Effective: 8/15/18 Pharmacy- Formulary 1 x Next Review: 6/18 Pharmacy- Formulary 2 x Date of Origin: 7/00 Injectable Fertility Medications: Bravelle,

More information

Preimplantation genetic diagnosis: polar body and embryo biopsy

Preimplantation genetic diagnosis: polar body and embryo biopsy Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director

More information

Information Booklet. Exploring the causes of infertility and treatment options.

Information Booklet. Exploring the causes of infertility and treatment options. Information Booklet Exploring the causes of infertility and treatment options www.ptafertility.co.za info@ptafertility.co.za +27 12 998 8854 Faith is taking the first step even if you don t see the whole

More information

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr.

Fertility 101. About SCRC. A Primary Care Approach to Diagnosing and Treating Infertility. Definition of Infertility. Dr. Dr. Shahin Ghadir A Primary Care Approach to Diagnosing and Treating Infertility St. Charles Bend Grand Rounds November 30, 2018 I have no conflicts of interest to disclose. + About SCRC State-of-the-art

More information

Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test*

Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test* FERTILITY AND STERILITY Copyright @ 1994 The American Fertility Society Printed on acid-free paper in U. s. A. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by

More information

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary

Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Subfertility Infertility: failure to conceive within one year of unprotected regular sexual intercourse. Primary secondary Infertility affects about 15 % of couples. age of the female. Other factors that

More information

Submitted April 2, 2003; accepted June 5, KEY WORDS: Fertility; fertilization; oocyte; reproductive techniques. INTRODUCTION

Submitted April 2, 2003; accepted June 5, KEY WORDS: Fertility; fertilization; oocyte; reproductive techniques. INTRODUCTION ( C 2003) Assisted Reproduction Estimation of Second Polar Body Retention Rate After Conventional Insemination and Intracytoplasmic Sperm Injection: In Vitro Observations From more than 5000 Human Oocytes

More information

Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle

Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle IN VITRO FERTILIZATION Benefit of intracytoplasmic sperm injection in patients with a high incidence of triploidy in a prior in vitro fertilization cycle Sunny H. Jun, M.D., a Thomas O Leary, B.S., b Katharine

More information

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara

More information

REPRODUCTIVE BIOLOGY. The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia

REPRODUCTIVE BIOLOGY. The Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, Virginia FERTILITY AND STERILITY VOL. 72, NO. 4, OCTOBER 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. REPRODUCTIVE BIOLOGY

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Applicable Injectable Fertility Medications: Bravelle, Cetrotide, Follistim AQ, Ganirelix, Gonal-F, human chorionic gonadotropin, leuprolide, Menopur, Novarel, Ovidrel, Pregnyl,

More information

K.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1

K.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1 Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and

More information

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age

The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G

More information

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte

More information

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre

Understanding eggs, sperm and embryos. Marta Jansa Perez Wolfson Fertility Centre Understanding eggs, sperm and embryos Marta Jansa Perez Wolfson Fertility Centre What does embryology involve? Aims of the embryology laboratory Creation of a large number of embryos and supporting their

More information

De Yi Liu, Ph.D.t Harold Bourne, B.Sc. H. W. Gordon Baker, M.D., Ph.D.

De Yi Liu, Ph.D.t Harold Bourne, B.Sc. H. W. Gordon Baker, M.D., Ph.D. FERTILITY AND STERILITY Vol. 64, No.1, July 1995 Copyright i) 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. i' I Fertilization and pregnancy with acrosome intact

More information

Causes of Infertility and Treatment Options

Causes of Infertility and Treatment Options Causes of Infertility and Treatment Options Dr Mrs.Kiran D. Sekhar Former vice President-FOGSI Former Chairperson- Genetics and Foetal medicine-fogsi Founder and Medical Director-Kiran Infertility centre

More information

Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer

Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer FERTILITY AND STERILITY Copyright tl 1989 The American Fertility Society Printed on acid-free paper in U. S.A. Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization

More information

Female age is an important parameter to predict treatment outcome in intracytoplasmic sperm injection*

Female age is an important parameter to predict treatment outcome in intracytoplasmic sperm injection* FERTILITY AND STERILITY Copyright 1996 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Female age is an important parameter to predict treatment outcome in intracytoplasmic

More information

Cryopreservation of human prophase I oocytes collected from unstimulated follicles

Cryopreservation of human prophase I oocytes collected from unstimulated follicles FERTILITY AND STERILITY Copyright c 1994 The American Fertility Society Vol. 61, No.6, June 1994 Printed on acid-free paper in U. S. A. Cryopreservation of human prophase I oocytes collected from unstimulated

More information

(BMI)=18.0~24.9 kg/m 2 ;

(BMI)=18.0~24.9 kg/m 2 ; 33 10 Vol.33 No.10 2013 10 Oct. 2013 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2013.10.0672 E-mail: randc_journal@163.com - ( 400013) : () GnRH-a - () : IVF- ET 233 A (I~II 102 ) B (III~IV

More information

The emergence of Personalized Medicine protocols for IVF.

The emergence of Personalized Medicine protocols for IVF. Individualising IVF: Introduction to the POSEIDON Concept Introduction The emergence of Personalized Medicine protocols for IVF. Differences between patients: age, ovarian reserve, BMI or presence of ovarian

More information

Ovarian response in three consecutive in vitro fertilization cycles

Ovarian response in three consecutive in vitro fertilization cycles FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in

More information

Understanding Infertility, Evaluations, and Treatment Options

Understanding Infertility, Evaluations, and Treatment Options Understanding Infertility, Evaluations, and Treatment Options Arlene J. Morales, M.D., F.A.C.O.G. Fertility Specialists Medical Group, Inc. What We Will Cover Introduction What is infertility? Briefly

More information

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success

Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27

More information

Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer

Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer CLINICAL ASSISTED REPRODUCTION Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer LUBNA PAL,1,3 JAN L. SHIFREN,2 KEITH B. ISAACSON,1 YuCHIAO CHANG,2 LUCY

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information